American Society of Addiction Medicine

This Week in Addiction Medicine from ASAM

American Society of Addiction Medicine

  • Lead Story: Association of Co-Prescribing of Opioid and Benzodiazepine Substitutes With Incident Falls and Fracture

Lead Story: Association of Co-Prescribing of Opioid and Benzodiazepine Substitutes With Incident Falls and Fracture

Tuesday 10th May 2022

Discover how co-prescribing opioids and gabapentinoids heightens fall risks in older adults, along with other vital updates in addiction medicine.
7 minutes
Informative
Educational
Thought-provoking
Raw
Non-judgmental

About this podcast

This Week in Addiction Medicine from ASAM
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Rounded Button Dark
Do you want to link to this podcast?
Get the buttons here!

Medications and Falls: Unpacking the Risks for Older Adults

Clinicians may be underestimating the sedating effects of gabapentinoids, putting patients at greater risk of falls and fractures.
Imagine juggling chronic pain and anxiety, only to find out that the medications meant to help might be increasing your risk of falls and fractures. This episode of 'Addiction Medicine Unpacked' takes a deep dive into a revealing cohort study that examines the effects of co-prescribing opioid and benzodiazepine substitutes among older adults.
The study, which analyzed data from nearly 48,000 Medicare enrollees, found that opioids combined with gabapentinoids posed a greater risk of falls and fractures than the more commonly discussed opioids and benzodiazepines. And if three or more of these medications are used together? The risk skyrockets. Clinicians may need to rethink the sedative effects of gabapentinoids to better protect their patients. But that's not all this episode covers.
You'll also hear about rising rates of stimulant use and related emergency incidents in Massachusetts, trends in cigarette smoking among adults with substance use disorders, and the latest on psychological interventions for gambling problems. Plus, get insights into emerging substances, dopamine supersensitivity, and the risks tied to psychedelic and MDMA-assisted therapies. Whether you're a healthcare professional, a caregiver, or someone navigating the complexities of addiction medicine, this episode offers crucial information and thought-provoking discussions to keep you informed.
alcoholfree.com
Published by The Mindful Drinking Company Limited
4 Providence Court, Pynes Hill, Exeter, Devon, EX2 5JL, England
Registered in England and Wales.
Company Number: 1195057. Vat Number: GB320915135.
Registered address as above.
© Copyright 2005-2025 The Mindful Drinking Company Limited.
All Rights Reserved.
alcoholfree.com is a participant in the Amazon Associates Programme, an affiliate advertising programme designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.co.uk. As an Amazon Associate, we earn from qualifying purchases.